BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36171756)

  • 1.
    Zhang Y; Zhang Q; Li H; Cong H; Qu Y
    Front Cell Infect Microbiol; 2022; 12():1002817. PubMed ID: 36171756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
    Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
    Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Histone Deacetylase (HDAC) Inhibitor with Pleiotropic In Vitro Anti-
    Jublot D; Cavaillès P; Kamche S; Francisco D; Fontinha D; Prudêncio M; Guichou JF; Labesse G; Sereno D; Loeuillet C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis.
    Mimura KK; Tedesco RC; Calabrese KS; Gil CD; Oliani SM
    Mol Vis; 2012; 18():1583-93. PubMed ID: 22740770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase SIR2 in Toxoplasma gondii modulates functions of murine macrophages in vitro and protects mice against acute toxoplasmosis in vivo.
    Yu Z; Chen S; Aleem M; He S; Yang Y; Zhou T; Liu J; Luo J; Yan R; Xu L; Song X; Li X
    Microb Pathog; 2021 May; 154():104835. PubMed ID: 33731306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous macular detachment in ocular toxoplasmosis: A review.
    Cirone D; Pellegrini F; Cuna A; Caruso E; Cimino L; Leonardi F
    Eur J Ophthalmol; 2024 Jan; 34(1):30-38. PubMed ID: 37016744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of ocular toxoplasmosis.
    Smith JR; Ashander LM; Arruda SL; Cordeiro CA; Lie S; Rochet E; Belfort R; Furtado JM
    Prog Retin Eye Res; 2021 Mar; 81():100882. PubMed ID: 32717377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak.
    Conceição AR; Belucik DN; Missio L; Gustavo Brenner L; Henrique Monteiro M; Ribeiro KS; Costa DF; Valadão MCDS; Commodaro AG; de Oliveira Dias JR; Belfort R
    Ophthalmology; 2021 Sep; 128(9):1346-1355. PubMed ID: 33711379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I and III interferons shape the retinal cytokine network and barrier function in an
    Geiller B; Greigert V; Hillenbrand CA; Gommenginger C; Beal L; Brunet J; Filisetti D; Villard O; Denis J; Pfaff AW
    Front Immunol; 2023; 14():1148037. PubMed ID: 37205102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1 levels and intraocular tissue alterations in mice infected with a virulent type I RH Toxoplasma gondii strain.
    Iqbal J; Al-Awadhi MA; Raghupathy RG
    Exp Parasitol; 2016 Mar; 162():57-63. PubMed ID: 26773166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.
    Leesombun A; Iijima M; Umeda K; Kondoh D; Pagmadulam B; Abdou AM; Suzuki Y; Ohba SI; Isshiki K; Kimura T; Kubota Y; Sawa R; Nihei CI; Nishikawa Y
    J Infect Dis; 2020 Feb; 221(5):766-774. PubMed ID: 31573038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal ferroptosis as a critical mechanism for the induction of retinochoroiditis during ocular toxoplasmosis.
    Yamada K; Tazaki A; Ushio-Watanabe N; Usui Y; Takeda A; Matsunaga M; Suzumura A; Shimizu H; Zheng H; Ariefta NR; Yamamoto M; Hara H; Goto H; Sonoda KH; Nishiguchi KM; Kato M; Nishikawa Y; Toyokuni S; Kaneko H
    Redox Biol; 2023 Nov; 67():102890. PubMed ID: 37738924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
    Garrett LA; Growdon WB; Rueda BR; Foster R
    J Ovarian Res; 2016 Sep; 9(1):58. PubMed ID: 27633667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific IgM, IgG and IgG1 directed against Toxoplasma gondii detected by flow cytometry and their potential as serologic tools to support clinical indirect fundoscopic presumed diagnosis of ocular disease.
    Martins LM; Rangel ALP; Peixe RG; Silva-Dos-Santos PP; Lemos EM; Martins-Filho OA; Bahia-Oliveira LMG
    J Immunol Methods; 2015 Feb; 417():97-106. PubMed ID: 25527345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.
    Nagineni CN; Pardhasaradhi K; Martins MC; Detrick B; Hooks JJ
    Infect Immun; 1996 Oct; 64(10):4188-96. PubMed ID: 8926087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study.
    Greigert V; Pfaff AW; Sauer A; Filisetti D; Candolfi E; Villard O
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31554726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor MS-275 augments expression of a subset of IFN-γ-regulated genes in Toxoplasma gondii-infected macrophages but does not improve parasite control.
    Sumpf K; Nast R; Downie B; Salinas G; Lüder CGK
    Exp Parasitol; 2017 Sep; 180():45-54. PubMed ID: 28189488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone deacetylase inhibitor LBH589 inhibits undifferentiated pleomorphic sarcoma growth via downregulation of FOS-like antigen 1.
    Saitoh Y; Bureta C; Sasaki H; Nagano S; Maeda S; Furukawa T; Taniguchi N; Setoguchi T
    Mol Carcinog; 2019 Feb; 58(2):234-246. PubMed ID: 30303565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.